ARRO Arrow Intl (MM)

READING, Pa., March 28 /PRNewswire-FirstCall/ -- Arrow International, Inc.'s (NASDAQ:ARRO) Chairman and Chief Executive Officer, Carl G. Anderson, Jr., will speak to the investment community today at 11:35 a.m. Eastern Time at the Sidoti & Company, LLC Eleventh Annual New York Emerging Growth Institutional Investor Forum. Interested investors can view the slides of Mr. Anderson's presentation on Arrow's web site following the start of the presentation at http://www.arrowintl.com/presentations/ In the presentation, Mr. Anderson will review second quarter and six months fiscal year 2007 financial results, released yesterday afternoon, financial targets for the second half and full fiscal year 2007 included in yesterday's press release and conference call, yesterday's announcement regarding relocation of all intra aortic balloon catheter manufacturing from Everett, MA to Hradec Kralove, Czech Republic, and the Company's decision to limit its involvement in the development of the CorAide(TM), the Company's left ventricular assist device licensed from the Cleveland Clinic Foundation, and seek an alternative arrangement. Mr. Anderson also will outline the Company's strategies for top line growth. Arrow International, Inc. develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists, and other health care providers. Arrow International's news releases and other company information can be found on the on its website at http://www.arrowintl.com/. The Company's common stock trades on the NASDAQ Global Select Market(SM) under the symbol ARRO. DATASOURCE: Arrow International, Inc. CONTACT: Frederick J. Hirt, CFO, Arrow International, Inc., +1-610-478-3117 Web site: http://www.arrowintl.com/ http://www.arrowintl.com/presentations

Copyright